Mandatum Life Insurance Company’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-37,714
Closed -$515K 93
2025
Q2
$515K Sell
37,714
-6,560
-15% -$92.5K 0.14% 55
2025
Q1
$680K Buy
44,274
+7,359
+20% +$115K 0.21% 50
2024
Q4
$564K Buy
36,915
+830
+2% +$13.3K 0.17% 53
2024
Q3
$589K Buy
36,085
+15,855
+78% +$272K 0.18% 48
2024
Q2
$381K Buy
20,230
+7,588
+60% +$147K 0.13% 58
2024
Q1
$249K Buy
+12,642
New +$255K 0.08% 69

Other funds holding OCSL

Mandatum Life Insurance Company's OCSL Position: Q3 2025 in Review

Mandatum Life Insurance Company sold out of Oaktree Specialty Lending (OCSL) in Q3 2025, closing a stake of 37,714 shares — an estimated $515K sold.

Mandatum Life Insurance Company first reported a position in OCSL in Q1 2024 and held it in 6 quarters. The position peaked at $680K in Q1 2025. 185 funds tracked by Wall St. Rank hold OCSL as of Q3 2025.

  • Mandatum Life Insurance Company reported no remaining Oaktree Specialty Lending position as of Q3 2025 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 37,714 Oaktree Specialty Lending shares in Q3 2025, an estimated $515K.
  • Mandatum Life Insurance Company first reported a position in Oaktree Specialty Lending in Q1 2024 and held it in 6 quarters.
  • Mandatum Life Insurance Company's Oaktree Specialty Lending position peaked at $680K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q3 2025.

Based on Mandatum Life Insurance Company's 13F filing for Q3 2025, filed 6 Nov 2025.